Загрузка...
Identification and Preclinical Pharmacology of the γ-Secretase Modulator BMS-869780
Alzheimer's disease is the most prevalent cause of dementia and is associated with accumulation of amyloid-β peptide (Aβ), particularly the 42-amino acid Aβ1-42, in the brain. Aβ1-42 levels can be decreased by γ-secretase modulators (GSM), which are small molecules that modulate γ-secretase, an...
Сохранить в:
Главные авторы: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Формат: | Artigo |
Язык: | Inglês |
Опубликовано: |
Hindawi Publishing Corporation
2014
|
Предметы: | |
Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4109680/ https://ncbi.nlm.nih.gov/pubmed/25097793 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2014/431858 |
Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|